Furthermore, this study not only comprehensively evaluated demographic data but also oncologic data for each group of patients, including CEA and CA 125 tumor markers, ECOG and tumor stage at the time of diagnosis, and the type of treatment the patients received. This evidence concerns the gene CEACAM5 and neoplasm.